Manhattan BioSolutions, Inc is a privately held biotechnology company focused on the development of biologic immunotherapies targeting host defense pathways for the treatment of advanced cancers. The company advances two technology platforms for drug discovery: RNA-degrader proteins, and antibody-drug conjugates (ADCs) - through collaborations with leading academic institutions.
United StatesCreated 4 months ago
Updated 4 months ago
Registration email verified ✔
Viral Press Releases makes every effort to ensure the business information provided by the business owner is accurate and up-to-date. We are not liable for any products or services provided by the business.
All the content in published press releases at Viral Press Releases is written and submitted by the press release author.
Viral Press Releases DO NOT accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in any published press release on viralpressreleases.com
If you have any question regarding some information in a press release, please contact the person listed in 'Media Contacts ' at the bottom of press release page.
Please DO NOT attempt to contact Viral Press Releases. We will be unable to assist you with any information regarding any published press release on Viral Press Releases.
Viral Press Releases disclaims any content contained in any published press release on Viral Press Releases.